NFKB1 and kidney disorder: NF-κB is well documented in various renal disorders [18,19], and its activation is essential for renal damage in metabolic syndrome, diabetes, and HFD exposure, with pharmacological inhibition offering protective benefits [20,21,22,23,24,25].